Ramanan AV, Quartier P, Okamoto N, Foeldvari I, et al. Baricitinib in juvenile idiopathic arthritis: an international, phase 3, randomised, double-blind, placebo-controlled, withdrawal, efficacy, and safety trial. Lancet 2023;402:555-570.
PMID: 37423231